GHRL and Cachexia: In a similar cohort receiving anabolic ghrelin mimetic anamorelin therapy, subgroup analyses revealed patients with body mass indices < 18.5 (and presumably severe cachexia) showed no improvements in body composition (Temel et al, 2016).